RESEARCH TRIANGLE PARK, N.C. – May 31, 2005 – Quintiles Inc., the North American clinical development subsidiary of Quintiles Transnational Corp., and Miami Children's Hospital in Florida today announced an alliance for clinical research.
The alliance allows Quintiles and Miami Children's Hospital to collaborate on clinical research that will give investigators access to an increased number and variety of clinical trials, provide the children of South Florida access to new medicines, and provide an opportunity to train new clinical investigators at Miami Children's Hospital.
Through the alliance, Quintiles' customers will be better able to meet increasing regulatory requirements for pediatric clinical trials. Most prescription drugs are approved based on safety and efficacy studies in adult populations. The FDA is requiring more pediatric clinical research so that physicians have more information on the safety, efficacy and appropriate dose of a medication before prescribing it for children.
"The more information we have about how children respond to medicines and at what doses, the better decisions physicians and parents will be able to make," said Adam Chasse, Director, Patient and Site Management Services, Quintiles. "By working with Miami Children's Hospital, we will help our customers – the companies who sponsor clinical research – obtain that vital information through a faster and more efficient process."
"Clinical research is one of the ways the physicians at Miami Children's Hospital provide leading edge care to the children of South Florida. Clinical research enables physicians and patients to participate in the process of healthcare innovation, by testing new alternatives to the standard of care. The alliance with Quintiles is an important catalyst to the growth of pediatric clinical research at Miami Children's Hospital," said Stuart Horowitz, PhD, Director of the Research Institute at Miami Children's Hospital.
"The alliance with Quintiles will allow a greater portion of the 185,000 pediatric patients we see each year to participate in clinical trials and have access to new and innovative medicines, diagnostic procedures, and medical devices," said Dr. Christian Patrick, MD, PhD, Chief Medical Officer and Sr. Vice President for Medical Affairs at Miami Children's Hospital. "The alliance also gives both Quintiles and the hospital the opportunity to share medical and clinical research expertise in pediatrics, which will ultimately benefit the children of South Florida."
As part of the agreement, Quintiles will provide guidance to assist Miami Children's Hospital with enhancing its infrastructure to support more clinical research. Quintiles also will work with the hospital to expand access to clinical trials for established investigators and train new investigators capable of conducting clinical research under Good Clinical Practice (GCP) guidelines.
About Miami Children's Hospital
Founded in 1950, Miami Children's Hospital is the only licensed specialty hospital for children in South Florida. Ranked among the country's best pediatric hospitals by U.S. News & World Report, Miami Children's Hospital offers medical care and services for children from birth to age 21. The 268-bed medical facility treats more than 185,000 patients each year and has expertise in all aspects of pediatric medicine.
Quintiles helps improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. Headquartered near Research Triangle Park, North Carolina, Quintiles has offices in 50 countries and is the world's leading pharmaceutical services organization. For more information visit the company's Web site at www.quintiles.com.